Susquehanna International Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Susquehanna International Group’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-121,200	Closed	-$1.99M	–	13830
2023 Q4	$1.99M	Buy	+121,200	New	+$1.91M	﹤0.01%	5356
2022 Q1	–	Sell	-1,800	Closed	-$24K	–	14263
2021 Q4	$24K	Sell	1,800 -6,740	-79%	-$111K	﹤0.01%	12795
2021 Q3	$196K	Buy	8,540 +1,340	+19%	+$39.9K	﹤0.01%	11508
2021 Q2	$316K	Sell	7,200 -3,070	-30%	-$171K	﹤0.01%	10670
2021 Q1	$746K	Sell	10,270 -2,430	-19%	-$173K	﹤0.01%	8490
2020 Q4	$549K	Buy	12,700 +9,040	+247%	+$405K	﹤0.01%	8079
2020 Q3	$150K	Buy	+3,660	New	+$189K	﹤0.01%	9684

Susquehanna International Group's ORTX Position: Q1 2024 in Review

Susquehanna International Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 34,028 shares — an estimated $560K sold.

Susquehanna International Group first reported a position in ORTX in Q3 2020 and held it in 8 quarters. The position peaked at $1.17M in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Susquehanna International Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Susquehanna International Group sold 34,028 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $560K.
Susquehanna International Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2020 and held it in 8 quarters.
Susquehanna International Group's Orchard Therapeutics plc American Depositary Shares position peaked at $1.17M in Q1 2021.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.